Resolvin D1 prevents injurious neutrophil swarming in transplanted lungs
Open Access
- 24 July 2023
- journal article
- research article
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 120 (31)
Abstract
Neutrophils are the primary cell type involved in lung ischemia-reperfusion injury (IRI), which remains a frequent and morbid complication after organ transplantation. Endogenous lipid mediators that become activated during acute inflammation-resolution have gained increasing recognition for their protective role(s) in promoting the restoration of homeostasis, but their influence on early immune responses following transplantation remains to be uncovered. Resolvin D1, 7 S ,8 R ,17 S -trihydroxy-4 Z ,9 E ,11 E ,13 Z ,15 E ,19 Z -docosahexaenoic acid (RvD1), is a potent stereoselective mediator that exhibits proresolving and anti-inflammatory actions in the setting of tissue injury. Here, using metabololipidomics, we demonstrate that endogenous proresolving mediators including RvD1 are increased in human and murine lung grafts immediately following transplantation. In mouse grafts, we observe lipid mediator class switching early after reperfusion. We use intravital two-photon microscopy to reveal that RvD1 treatment significantly limits early neutrophil infiltration and swarming, thereby ameliorating early graft dysfunction in transplanted syngeneic lungs subjected to severe IRI. Through integrated analysis of single-cell RNA sequencing data of donor and recipient immune cells from lung grafts, we identify transcriptomic changes induced by RvD1. These results support a role for RvD1 as a potent modality for preventing early neutrophil-mediated tissue damage after lung IRI that may be therapeutic in the clinics.Keywords
Funding Information
- HHS | NIH | National Institute of General Medical Sciences (R35 GM1 39430)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (1P01AI116501)
- HHS | NIH | National Heart, Lung, and Blood Institute (R01HL094601)
- HHS | NIH | National Heart, Lung, and Blood Institute (R01HL151078)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (U01163086-01)
- Veterans Administration Medical Center, Yale School of Medicine (1I01BX002730)
This publication has 44 references indexed in Scilit:
- Intravital 2-photon imaging of leukocyte trafficking in beating heartJournal of Clinical Investigation, 2012
- Infection regulates pro-resolving mediators that lower antibiotic requirementsNature, 2012
- Emergency granulopoiesis promotes neutrophil-dendritic cell encounters that prevent mouse lung allograft acceptanceBlood, 2011
- In vivo two-photon imaging reveals monocyte-dependent neutrophil extravasation during pulmonary inflammationProceedings of the National Academy of Sciences, 2010
- Resolvin D1 binds human phagocytes with evidence for proresolving receptorsProceedings of the National Academy of Sciences, 2010
- Tonic inhibition of chemotaxis in human plasmaProceedings of the National Academy of Sciences, 2008
- Resolvin E1, an EPA-derived mediator in whole blood, selectively counterregulates leukocytes and plateletsBlood, 2008
- Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsNature Reviews Immunology, 2008
- TNF-α-induced up-regulation of intercellular adhesion molecule-1 is regulated by a Rac-ROS-dependent cascade in human airway epithelial cellsExperimental & Molecular Medicine, 2008
- Intraluminal crawling of neutrophils to emigration sites: a molecularly distinct process from adhesion in the recruitment cascadeJournal of Experimental Medicine, 2006